What is your preferred systemic regimen for MMR-proficient, high-grade endometrial cancer that recurs <1 year from adjuvant carboplatin/paclitaxel?

What is your next-line treatment regimen for recurrent MMRp endometrial cancer that has already been treated with a platinum-based regimen?

• Repeat platinum-based chemotherapy regimen if >6 months since last platinum
• Repeat platinum-based chemotherapy regimen if >12 months since last platinum
• Repeat platinum-based chemotherapy regimen regardless of time since last platinum
• Lenvatinib/Pembrolizumab if <6 months since platinum-based chemotherapy
• Lenvatinib/Pembrolizumab if <12 months since platinum-based chemotherapy
• Lenvatinib/Pembrolizumab regardless of time since platinum-based chemotherapy
• Other chemotherapy regimen if <6 months since platinum-based chemotherapy
• Other chemotherapy regimen if <12 months since platinum-based chemotherapy
• Other chemotherapy regimen regardless of time since platinum-based chemotherapy
• Other